Answers are grounded in this paper and cite their sources.
AIMS/INTRODUCTION: Diabetic polyneuropathy (DPN) is common in patients with diabetes. Its symptoms include pain, numbness, and impaired neurosensory function. ONO-2910 promotes Schwann cell differentiation and is being developed for DPN. MATERIALS AND METHODS: This Phase IIa randomized controlled trial evaluated the effectiveness and safety of ONO-2910 in Japanese patients with type 2 diabetes and DPN. Patients were randomized to ONO-2910 (300 mg/day) or placebo, once daily, for 12 weeks. The primary endpoints were the changes in the sum scores for numbness and tingling (modified Toronto Clinical Neuropathy Scores [mTCNS]) and safety. RESULTS: The ONO-2910 and placebo groups comprised 76 (safety: 77 patients) and 77 patients, respectively. The mean (standard deviation) age and time since DPN diagnosis were 62.6 (8.48) and 4.89 (5.662) years, respectively. The least-squares mean (LSM) change in mTCNS sum scores for numbness and tingling at 12 weeks was -1.0 in both groups (LSM difference: 0.0; 95% confidence interval -0.4 to 0.4). The LSM changes in the mTCNS total scores were -2.6 (0.64) and -2.3 (0.67) in the ONO-2910 and placebo groups, respectively. There were no marked changes in nerve function and nerve conduction velocities in the ONO-2910 and placebo groups. Treatment-emergent adverse events (TEAEs) occurred in 37 (48.1%) and 39 (50.6%) patients in the ONO-2910 and placebo groups, respectively. TEAEs in ≥2 patients in the ONO-2910 group were nasopharyngitis (5 patients), diarrhea (3 patients), nausea (2 patients), and eczema (2 patients). CONCLUSIONS: ONO-2910 was generally well-tolerated in Japanese patients with DPN. There were no obvious improvements in DPN symptoms or neurosensory function among patients who received ONO-2910 versus placebo. CLINICAL TRIAL REGISTRY: Japan Primary Registries Network jRCT2061210008.
No takes yet. Share an insight, caveat, or question.
Onishi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: